| FLARE |  | ||
---|---|---|---|---|
 | NO | YES |  | |
 | N (%) | N (%) | p-value* | |
Sex | Male | 55 (61.1 %) | 35 (38.9 %) | p = 0.706 |
Female | 29 (64.4Â %) | 16 (35.6Â %) | ||
Cancer Site | Lung | 23 (54.8 %) | 19 (45.2 %) | p = 0.358 |
Prostate | 16 (59.3Â %) | 11 (40.7Â %) | ||
Breast | 15 (78.9Â %) | 4 (21.1Â %) | ||
Others | 30 (63.8Â %) | 17 (36.2Â %) | ||
Bisphosphonates | YES | 23 (63.9 %) | 13 (36.1 %) | p = 0.810 |
NO | 61 (61.6Â %) | 38 (38.4Â %) | ||
RT Dose | 8 Gy/ 1 fx | 28 (66.7 %) | 14 (33.3 %) | p = 0.091 |
20Â Gy / 5 fx | 47 (56.6Â %) | 36 (43.4Â %) | ||
Other | 9 (90.0Â %) | 1 (10.0Â %) | ||
Dexamethasone during RT | YES | 25 (56.1 %) | 18 (43.9 %) | p = 0.379 |
NO | 59 (64.1Â %) | 33 (35.9Â %) |